Protumor Macrophage Polarization Mediated by BMP2/4-ACVR1 Signaling Orchestrates an Immunosuppressive Microenvironment during Tumor Initiation.
1/5 보강
[UNLABELLED] Cancer cells are able to evade immunosurveillance by engendering an immunosuppressive "cold" tumor microenvironment (cTME).
APA
Wang M, Song Z, et al. (2026). Protumor Macrophage Polarization Mediated by BMP2/4-ACVR1 Signaling Orchestrates an Immunosuppressive Microenvironment during Tumor Initiation.. Cancer research, 86(4), 954-971. https://doi.org/10.1158/0008-5472.CAN-24-4392
MLA
Wang M, et al.. "Protumor Macrophage Polarization Mediated by BMP2/4-ACVR1 Signaling Orchestrates an Immunosuppressive Microenvironment during Tumor Initiation.." Cancer research, vol. 86, no. 4, 2026, pp. 954-971.
PMID
41248425 ↗
Abstract 한글 요약
[UNLABELLED] Cancer cells are able to evade immunosurveillance by engendering an immunosuppressive "cold" tumor microenvironment (cTME). A better understanding of the mechanisms underlying the establishment of a cTME in the initial phases of tumor formation could help uncover improved immunotherapeutic strategies. To characterize the temporal dynamics of the formation of a cTME, we generated single-cell RNA sequencing data during the initiation phases of EGFR-driven lung adenocarcinoma. Macrophages in the tumor microenvironment (TME) underwent a state transition from antitumor macrophages to protumor macrophages, which orchestrated the formation of a cTME. Tumor cell-derived BMP2/4 induced the polarization of protumor macrophages, and inhibiting the BMP2/4-ACVR1 axis with an ACVR1 inhibitor converted the cTME into a "hot" TME, resulting in a potent suppression of tumor growth. Furthermore, patients with EGFR-mutant lung adenocarcinoma exhibited similar cTME characteristics to those observed in mice, and high expression of ACVR1 correlated with worse patient prognosis. Overall, in addition to elucidating the role of protumor macrophages in cTME formation, this study pinpoints targeting ACVR1 as a therapeutic strategy for treating EGFR-mutant lung cancers.
[SIGNIFICANCE] In the early stages of lung cancer development, cancer cells reprogram tumor-associated macrophages via BMP2/4-ACVR1 signaling to stimulate the formation of an immunosuppressive tumor microenvironment, establishing ACVR1 as a potential immunotherapeutic target.
[SIGNIFICANCE] In the early stages of lung cancer development, cancer cells reprogram tumor-associated macrophages via BMP2/4-ACVR1 signaling to stimulate the formation of an immunosuppressive tumor microenvironment, establishing ACVR1 as a potential immunotherapeutic target.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Rutin targets PD-L1 for the treatment of atopic dermatitis: network pharmacological analysis and experimental evidence.
- Associations of electronic health literacy with related factors in individuals diagnosed with colorectal cancer: a cross-sectional analysis.
- Perioperative penpulimab-based combination therapy in patients with resectable non-small cell lung cancer (ALTER-L043): an open-label, multicenter, randomized, phase II trial.
- The research advances of crosstalk between cancer-associated fibroblasts and tumor cells using co-culture organoids.
- The gene-panel obtained by anti-PD-1 monotherapy for melanoma reveals prognostic markers and therapeutic targets.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.